RegMed Forum 2026 - Clinical Translation of Advanced Therapeutic Approaches
RegMed Forum 2026 explores challenges and experiences in translating ATMPs and advanced medical devices to clinical benefit.
Intro
Advances in medical life sciences, biotechnology and material science allow for increasingly complex and unconventional but patient tailored therapeutic approaches with a tremendous, often curative, potential.
Within this year’s RegMed forum, we want to bring together actors from academia, start-ups and industry from all over Germany and beyond, to share their experiences on the challenges in the clinical translation of advanced therapeutic approaches including Advanced Therapy Medicinal Products (ATMPs) as well as advanced medical devices and combined products. This includes specifically aspects of manufacturing, regulatory requirements and clinical trials
Furthermore, we invite structural programmes
Furthermore, we invite structural programmes in Germany which want to support and enable these innovations to allow goal-oriented preclinical development, accelerated clinical translation and patient access to novel high-quality therapeutic options.
To underline the national importance of this topic, we involve Munich as a co-organizer and perspectively want to enlarge this to further stakeholders.
Our target audience includes academia, start-ups and industry with translational scientists, physicians with interest in clinical trials, manufacturers, clinical trial sponsors and providers of innovative therapies to enable active exchange of experiences, concepts and strategies for a more efficient clinical translation of novel therapies within Germany and Europe.
This event is organized by the BIH Center for Regenerative Therapies (BCRT) @Charité, Berlin Partner, HealthCapital Berlin-Brandenburg, the national network office GCT Germany as well as the German Stem Cell Network supported by Martin Hildebrandt from Technical University of Munich.
Program
Program
8:30 am | Registration
9:00 am | Welcome and Introduction
- Dr. Leila Amini (BeCAT, BIH BCRT)
- Dr. Daniel Besser (German Stem Cell Network)
- Prof. Dr. Martin Hildebrandt (TU München)
- Dr. Elke Luger (National Network Office Gene and Cell Therapies)
- Jasmin Podufall (Berlin Partner)
9:05 am | Keynote Lecture
- Prof. Dr. Ulrike Köhl (Fraunhofer Institute for Cell Therapy & Immunology Leipzig, Clinical Immunology at the University of Leipzig)
9:50 am | Lecture
- Prof. Dr. Angelika Eggert (Medical Director/CEO University Medicine Essen)
10:20 am | Coffee Break & Networking
10:50 am | Lectures & Industry Speed Talk
- Dr. Jens Schröder (Treefrog)
- Prof. Dr. Christof von Kalle (BIH & Luxembourg Institute of Health (LIH))
- Dr. Elisa Kieback (Tknife)
12:15 pm | Panel Discussion | Translation Acceleration - How Can Network Structures Promote the Process of Translation?
- Christopher Baum (Spokesperson National Strategy for Gene and Cell Therapy)
- Kai Bindseil (HealthCapital)
- Elke Luger (National Network Office Gene an Cell Therapies)
- Pablo Serrano (Bundesverband der Pharmazeutischen Industrie)
- Lenka Suckova (ECRIN/CzeCRIN)
01:00 pm | Lunch Break & Networking
02:15 pm | Keynote Lecture
- Prof. Dr. Gerhard Krönke MHBA (Charité/Laboratory Berlin Charité Vivantes GmbH)
03:00 pm | Lectures
- Prof. Dr. Georg Duda (Charité – Universitätsmedizin Berlin | BIH)
- Prof. Dr. Barbara Ludwig (Universitätsmedizin Dresden)
04:00 pm | Panel Discussion | Between responsibility and innovation - How much risk can medical technology improvement tolerate?
- Annette Künkele (Charité – Universitätsmedizin Berlin)
- Ralf Sanzenbacher (Paul-Ehrlich-Institut)
- Sebastian Sethe
- Alexandra Skorupa (Novartis)
- Oliver Zolk (Member of the Ethics Committee State of Berlin)
04:45 pm | Coffee Break & Networking
05:15 pm | Lectures & Industry Speed Talk
- Michael Schmitt (Universitätsklinikum Heidelberg)
- Boris Schmitt (GrownValve)
- Stefaan Van der Spiegel (European Commision)
06:30 pm | Closing remarks & Farewell
06:35 pm | Evening Reception & Get Together
Logos
![[Translate to englisch:] Zur Webseite von BIH BCRT](/fileadmin/_processed_/c/4/csm_BIH-Regeneration_Logo_rgb_0b2a87a7c7.webp){kind=logo}
![[Translate to englisch:] Zur Webseite von Berlin Partner](/fileadmin/_processed_/d/c/csm_Berlin_Partner_e5102608a6.webp)
![[Translate to englisch:] zur Webseite der https://www.healthcapital.de/](/fileadmin/_processed_/e/a/csm_HealthCapital_BerlinBrandenburg_28d22dc78f.webp)
![[Translate to englisch:] Zur Webseite NAtionale Strategien Gen- und zellbasierte Therapien Netzwerkbüro](/fileadmin/_processed_/2/5/csm_GCT_19ab8a60f4.webp)
![[Translate to englisch:] Zur Webseite von Berlin Center for Advanced Therapies](/fileadmin/_processed_/d/4/csm_BeCat_c23168081d.webp)
What to expect?
What to expect?
- Talks & panel discussions with different stakeholders.
- Onsite networking opportunity.
- Industry exhibition to present your products and services
Registration
Registration
Charité/BIH employees are kindly asked to register by sending an email to Anne-Christin Schöne.
External participants, please use the link below to complete your registration.
Registration fee
• Participation fee: 50,00 €
• Student participation fee: 20,00 €
Industry Exhibition
Industry Exhibition
If you are interested in participating in our industry exhibition at the upcoming RegMed Forum on 19 February 2026? There are several options available to you. For further information, please contact Anne-Christin Schöne.
Exhibitors
![[Translate to englisch:] Logo AcroBiosystems](/fileadmin/_processed_/d/7/csm_2026_regmed_acro_logo_a78698f94f.webp){kind=logo}
![[Translate to englisch:] Aldevron](/fileadmin/_processed_/a/9/csm_2026_Regmed_aldevron_c3ba6d3362.webp)
![[Translate to englisch:] Macherey-Nagel](/fileadmin/_processed_/e/f/csm_2026_regmed_MN_Logo_kompakt_mit_Webadresse_68191b77c8.webp){kind=logo}
![[Translate to englisch:] Logo Miltenyi](/fileadmin/_processed_/2/a/csm_2026_regmed_miltenyibiotec_logo_c03a289e95.webp){kind=logo}
Exhibitors 2
![[Translate to englisch:] Renatrix](/fileadmin/_processed_/0/8/csm_2026_Regmed_RENATRIX_With_tag_line_8064b50914.webp)
![[Translate to englisch:] Sartorius](/fileadmin/_processed_/6/8/csm_2026_Regmed_Satorius_506e392d26.webp)
![[Translate to englisch:] valicare](/fileadmin/_processed_/c/2/csm_2026_Regmed_valicare_81de397518.webp)
You should attend if you...
You should attend if you...
- Develop or manufacture innovative therapeutic approaches
- Provide services or products that support the field of therapy development, manufacturing and translation
- Want to learn about academic vs. industrial settings for therapy development
- Expand your knowledge about clinical trials innovative products
- Explore new partnership opportunities for your institution
- Wish to expand your professional network
Who will be attending?
Who will be attending?
- Academic researchers
- manufacturers
- pharma companies
spin-offs/start-ups
…interested in clinical translation of innovative therapies
Info
When:
February 19, 2026
8:30 am
Where:
Kaiserin Friedrich Haus
Robert-Koch-Platz 7
10115 Berlin
Please note that the venue is not accessible for individuals with mobility impairments.
Registration:
Charité/BIH employees are kindly asked to register by sending an email to Anne-Christin Schöne.
External participants, please use the link below to complete your registration.
![[Translate to englisch:]](/fileadmin/_processed_/a/d/csm_May2023_Anne_Sch%C3%B6ne_1ffa5e4bd0.webp "[Translate to englisch:]")